|
YTHDF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.71140001748694E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.28060000171138E-08 |
| Normal-vs-Stage2 |
1.03620000002635E-06 |
| Normal-vs-Stage3 |
3.683900E-03 |
| Normal-vs-Stage4 |
2.024600E-04 |
| Stage1-vs-Stage2 |
4.021800E-01 |
| Stage1-vs-Stage3 |
4.710400E-01 |
| Stage1-vs-Stage4 |
8.470200E-01 |
| Stage2-vs-Stage3 |
2.377800E-01 |
| Stage2-vs-Stage4 |
4.386800E-01 |
| Stage3-vs-Stage4 |
5.686400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00360000310218E-08 |
| Normal-vs-AfricanAmerican |
1.44209999997091E-06 |
| Normal-vs-Asian |
2.169800E-02 |
| Caucasian-vs-AfricanAmerican |
8.196000E-01 |
| Caucasian-vs-Asian |
7.428000E-01 |
| AfricanAmerican-vs-Asian |
7.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09950004656412E-09 |
| Normal-vs-Female |
3.998800E-04 |
| Male-vs-Female |
1.671570E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.448250E-04 |
| Normal-vs-Extreme_Weight |
2.03539995968782E-09 |
| Normal-vs-Obese |
5.61239999999907E-05 |
| Normal-vs-Extreme_Obese |
6.819500E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.055000E-01 |
| Normal_Weight-vs-Obese |
9.429200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.177000E-01 |
| Extreme_Weight-vs-Obese |
2.568800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.249400E-01 |
| Obese-vs-Extreme_Obese |
7.899200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.517800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.70710000030527E-07 |
| Normal-vs-Age(61-80Yrs) |
3.006599968991E-09 |
| Normal-vs-Age(81-100Yrs) |
2.38870000000002E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.362800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.843430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.354230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.569220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.993980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.769800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17439999339319E-09 |
| Normal-VS-Type2 PRCC |
2.20659999999873E-05 |
| Normal-VS-KIRP CIMP |
3.916400E-02 |
| Normal-VS-Unclassified PRCC |
1.603640E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.386200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.802600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.803800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.267600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.629600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.358800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.94010002191925E-09 |
| Normal-vs-N1 |
1.017550E-02 |
| Normal-vs-N2 |
5.84959999999635E-05 |
| N0-vs-N1 |
2.176400E-02 |
| N0-vs-N2 |
2.136600E-01 |
| N1-vs-N2 |
5.002100E-02 |
|
|
